This compound is a pharmaceutical intermediate featuring a complex aromatic structure with amide, ester, and ether functional groups. Its significance lies in its role as a building block for the synthesis of other chemical entities.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 2204442-52-2
N,N'-Bis[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea
research compound
2,4-Dimethyl-5-nitrobenzoic acid
Pharmaceutical intermediate
5-Fluoro-2-methylbenzaldehyde
Pharmaceutical intermediate
1-Benzylpiperidine-4-carbaldehyde
pharmaceutical intermediate
Methyl 5-chloro-6-methoxynicotinate
pharmaceutical intermediate
4,4'-(((carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(oxy))bis(N-methylpicolinamide)
Regorafenib impurity reference standard
methyl 4-[4-[[4-[[2-(methylcarbamoyl)-4-pyridinyl]oxy]phenyl]carbamoylamino]phenoxy]pyridine-2-carboxylate
LYFLMAXULJNQKQ-UHFFFAOYSA-N
CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)OC4=CC(=NC=C4)C(=O)OC